Proteome and metabolome alterations in heart and liver indicate compromised energy production during sepsis

Protein and Peptide Letters

Volumn 17, Issue 1, 2010, Pages 18-31

  Hinkelbein, Jochen ^a,b   Kalenka, Armin ^a,b   Schubert, Charlotte ^a,b   Peterka, Anna ^a,b   Feldmann Jr , Robert E ^b  

^a University Medicine Mannheim   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiac dysfunction; Cecal ligature and puncture; Heart; Liver dysfunction; Protein alterations; Protein expression; Proteomics; Sepsis

Indexed keywords

PROTEOME;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; DISEASE MODEL; GENE EXPRESSION PROFILING; HEART MUSCLE; LIVER; MALE; METABOLISM; METABOLOME; METHODOLOGY; PEPTIDE MAPPING; RAT; SEPSIS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; LIVER; MALE; METABOLOME; MYOCARDIUM; PEPTIDE MAPPING; PROTEOME; RATS; RATS, WISTAR; SEPSIS; SIGNAL TRANSDUCTION;

RATTUS; RATTUS NORVEGICUS;

EID: 77949951419     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610789909520     Document Type: Article

References (57)

1. Fink, M.P. Cytopathic hypoxia. Crit Care Clin, 2001, 17(1), 219-237.
2. Hasselgren, P.O.; Fischer, J.E. Septic encephalopathy. Intensive Care Med, 1986, 12, 13-16.
3. Hinkelbein, J.; Feldmann, R.E. Jr.; Peterka, A.; Schubert, C.; Schelshorn, D.; Maurer, M.H.; Kalenka, A. Alterations in cerebral metabolomics and proteomic expression during sepsis. Curr Neurovasc Res, 2007, 4(4), 280-288.
4. Stochetti, N. Brain and Sepsis: Functional Impairment, Structural Damage, and Markers. Anesth Analg, 2005, 101, 1463-1464.
5. Brealey, D.; Brand, M.; Hargreaves, I.; Heales, S.; Land, J.; Smolenski, R.; Davies, N.A.; Cooper, C.E.; Singer, M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet, 2002, 360, 219-223.
6. Deitch, E.A. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg, 1992, 216, 117-134.
7. Fink, M.; Heard, S. Laboratory models of sepsis and septic shock. J Surg Res, 1990, 49, 186-196.
8. Dellinger, R.; Carlet, J.; Masur, H.; Gerlach, H.; Calandra, T.; Cohen, J.; Gea-Banacloche, J.; Keh, D.; Marshall, J.; Parker, M.; Ramsay, G.; Zimmerman, J.; Vincent, J.; Levy, M. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med, 2004, 30(4), 536-555.
9. Gellerich, F.N.; Trumbeckaite, S.; Hertel, K.; Zierz, S.; Müller-Werdan, U.; Werdan, K.; Redl, H.; Schlag, G. Impaired Energy Metabolism in Hearts of Septic Baboons: Diminished Activities of Complex I and Complex II of the Mitochondrial Respiratory Chain. Shock, 1999, 11(5), 336-341.
10. Martin, G.; Mannino, D.; Eaton, S.; Moss, M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med, 2003, 348, 1546-1554.
11. Dellinger, R.P.; Levy, M.M.; Carlet, J.M.; Bion, J.; Parker, M.M.; Jaenschke, R.; Reinhart, K.; Angus, D.; Brun-Buisson, C.; Beale, R.; Calandra, T.; Dhainaut, J.F.; Gerlach, H.; Harvey, M.; Marini, J.J.; Marshall, J.; Ranieri, M.; Ramsay, G.; Sevransky, J.; Thompson, B.T.; Townsend, S.; Vender, J.S.; Zimmerman, J.L.; Vincent, J.L. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med, 2008, 34, 17-60.
12. Wang, P.; Ba, Z.F.; Chaudry, I.H. Hepatic Extraction of Indocyanine Green Is Depressed Early in Sepsis Despite Increased Hepatic Blood Flow and Cardiac Output. Arch Surg, 1991, 126, 219-224.
13. Mason, K.E.; Stofan, S.D.A. Endotoxin challenge reduces aconitase activity in myocardial tissue. Arch Biochem Biophys, 2008, 469, 151-156.
14. Lenz, K. Liver dysfunction in patients with sepsis and multiorgan failure. In: Engelmann, L.; Schuster, H.P. Diagnostik und Intensivtherapie bei Sepsis und Multiorganversagen. Steinkopf, Darmstadt, 2006.
15. Eley, A.; Hargreaves, T.; Lambert, H.P. Jaundice in severe infections. Brit Med J, 1965, 2, 75-77.
16. Garvin, I. Remarks on pneumonia biliosa. South Med J, 1896, 15, 36.
17. Mueller-Werdan, U.; Buerke, M.; Christoph, A.; Flieger, R.R.; Heinroth, K.; Herklotz, A.; Ruß, M.; Schlitt, A.; Schmidt, H.; Soeffker, G.; Werdan, K. Septic Cardiomyopathy. In: Engelmann L, Schuster HP. Diagnostik und Intensivtherapie bei Sepsis und Multiorganversagen. Steinkopf, Darmstadt, 2006.
18. Guest, T.M.; Ramanathan, A.V.; Tuteur, P.G.; Schechtman, K.B.; Ladenson, J.H.; Jaffe, A.S. Myocardial Injury in Critically Ill Patients: A Frequently Unrecognized Complication. J Am Med Assoc, 1995, 273(24), 1945-1949.
19. Levy, R.J. Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis. Shock, 2007, 28(1), 24-28.
20. Xie, Y.W.; Kaminski, P.M.; Wolin, M.S. Inhibition of Rat Cardiac Muscle Contraction and Mitochondrial Respiration by Endogenous Peroxynitrite Formation During Posthypoxic Reoxygenation. Circ Res, 1998, 82, 891-897.
21. Bazel, S.; Andrejko, K.M.; Chen, J.; Deutschman, C.S. Hepatic gene expression and cytokine responses to sterile inflammation: comparison with cecal ligation and puncture sepsis in the rat. Shock, 1999, 11(5), 347-355.
22. Hinkelbein, J.; Feldmann, R.E. Jr.; Peterka, A.; Schubert, C.; Schelshorn, D.; Maurer, M.; Kalenka, A. Alterations in cerebral metabolomics and proteomic expression during sepsis. Curr Neurovasc Res, 2007, 4(4), 280-288.
23. Hinkelbein, J.; Schroeck, H.; Peterka, A.; Schubert, C.; Kuschinsky, W.; Kalenka, A. Local cerebral blood flow is preserved in sepsis. Curr Neurovasc Res, 2007, 4(1), 39-47.
24. Wichterman, K.; Baue, A.; Chaudry, I. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res, 1980, 29, 189-201.
25. Hubbard, W.; Choudhry, M.; Schwacha, M.; Kerby, J.; III, L.R.; Bland, K.; Chaudry, I. Cecal ligation and puncture. Shock, 2005, 24(Suppl. 1), 52-57.
26. Kalenka, A.; Hinkelbein, J.; Feldmann, R.E. Jr.; Kuschinsky, W.; Waschke, K.; Maurer, M. The Effects of Sevoflurane Anesthesia on Rat Brain Proteins: A Proteomic Time-Course Analysis. Anesth Analg, 2007, 104(5), 1129-1135.
27. Kalenka, A.; Feldmann, R.E. Jr.; Otero, K.; Maurer, M.; Waschke, K.; Fiedler, F. Changes in the serum proteome of patients with sepsis and septic shock. Anesth Analg, 2006, 103(6), 1522-1526.
28. Bradford, M. A rapid and sensitive for the quantitation of microgram quantites of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72(5), 248-254.
29. Schlags, W.; Walther, M.; Masree, M.; Kratzel, M.; Noe, C.R.; Lachmann, B. Towards validating a method for two-dimensional electrophoresis/silver staining. Electrophoresis, 2005, 26(12), 2461-2469.
30. Perkins, D.; Pappin, D.; Creasy, D.; Cottrell, J. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis, 1999, 20(18), 3551-3567.
31. Maurer, M. Comparison of large Proteomic Datasets. Curr Proteomics, 2005, 2, 179-189.
32. Gerling, I.; Singh, S.; Lenchik, N.; Marshall, D.; Wu, J. New data analysis and mining approaches identify unique proteome and transcriptome markers of susceptibility to autoimmune diabetes. Mol Cell Proteomics, 2006, 5(2), 293-305.
33. Oliver, S.G.; Winson, M.K.; Kell, D.B.; Baganz, F. Systematic functional analysis of the yeast genome. Trends Biotechnol, 1998, 16(9), 373-378.
34. McDunn, J.E.; Townsend, R.R.; Cobb, J.P. The murine plasma protein response to polymicrobial intra-abdominal sepsis. Proteomics Clin Appl (online first), 2007, DOI 10.1002/prca.200600494
35. Anderson, L.; Seilhamer, J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis, 1997, 18, 533-537.
36. Anderson, N.; Anderson, N. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics, 2002, 1, 845-867.
37. Rittirsch, D.; Hoesel, L.; Ward, P. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol, 2007, 81(1), 137-143.
38. Chaudry, I.; Wichterman, K.; Baue, A. Effect of sepsis on tissue adenine nucleotide levels. Surgery, 1979, 85(2), 205-211.
39. Chaudry, I.H.; Wichterman, K.A.; Baue, A.E. Effect of sepsis on tissue adenine nucleotide levels. Surgery, 1979, 85(2), 205-211.
40. Dear, J.W.; Leelahavanichkul, A.; Aponte, A.; Hu, X.; Constant, S.L.; Hewitt, S.M.; Yuen, P.S.T.; Star, R.A. Liver proteomics for therapeutic drug discovery: Inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure. Crit Care Med, 2007, 35(10), 2319-2328.
41. Parrillo, J.E. The cardiovascular pathophysiology of sepsis. Ann Rev Med, 1989, 40, 469-485.
42. Oral, H.; II, G.W.D.; Mann, D.L. Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor alpha in the Adult Mammalian Cardiac Myocyte. J Biol Chem, 1997, 272(8), 4836-4842.
43. Ebdrup, L.; Krog, J.; Granfeldt, A.; Larsen, P.O.; Vestergaard, C.; Hokland, M.; Tonnesen, E. Leukocyte, plasma, and organ-associated cytokine profiles in an animal model of acute inflammation. APMIS, 2008, 116, 352-360.
44. Uyemura, S.A.; Albuquerque, S.; Curti, C. Energetics of Heart Mitochondria during Acute Phase of Trypanosoma cruzi Infection in Rats. Int J Biochem Cell Biol, 1995, 27(11), 1183-1189.
45. Levy, R.J.; Deutschman, C.S. Deficient mitochondrial biogenesis in critical illness: cause, effect, or epiphenomenon? Crit Care, 2007, 11, 158.
46. Sadek, H.A.; Humphries, K.M.; Szweda, P.A.; Szweda, L.I. Selective inactivation of redox-sensitive mitochondrial enzymes during cardiac reperfusion. Arch Biochem Biophys, 2002, 406, 222-228.
47. Kelm, M.; Schäfer, S.; Dahmann, R.; Dolu, B.; Perings, S.; Decking, U.K.M.; Schrader, J.; Strauer, B.E. Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. Cardiovasc Res, 1997, 36, 185-194.
48. Levy, R.J.; Deutschman, C.S. Cytochrome c odidase dysfunction in sepsis. Crit Care Med, 2007, 35(9), S468-S475.
49. Vary, T.C.; Martin, L.F. Potentiation of Decreased Pyruvate Dehydrogenase Activity by Inflammatory Stimuli in Sepsis. Circ Shock, 1993, 39, 299-305.
50. Andrejko, K.M.; Deutschman, C.S. Altered hepatic gene expression in fecal peritonitis: changes in transcription of gluconeogenic, ß-oxidative, and ureagenic genes. Shock, 1997, 7(3), 164-169.
51. Lucas, D.T.; Szweda, L.I. Declines in mitochondrial respiration during cardiac reperfusion: Age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc Natl Acad Sci, 1999, 96, 6689-6693.
52. Vary, T.C.; Siegel, J.H.; Nakatani, T.; Sato, T.; Aoyama, H. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol, 1986, 250(6 Pt 1), E634-E640.
53. Kantrow, S.P.; Taylor, D.E.; Carraway, M.S.; Piantadosi, C.A. Oxidative Metabolism in Rat Hepatocytes and Mitochondria during Sepsis. Arch Biochem Biophys, 1997, 345(2), 278-288.
54. Singleton, K.; Wischmeyer, P. Distance of Cecum Ligated Influences Mortality, Tumor Necrosis Factor-Alpha and Interleukin-6-Expression following Cecal Ligation and Puncture in the Rat. Eur Surg Res, 2003, 35, 486-491.
55. Santoni, V.; Molloy, M.; Rabilloud, T. Membrane proteins and proteomics: un amour impossible? Electrophoresis, 2000, 21, 1054-1070.
56. Braun, R.J.; Kinkl, N.; Beer, M.; Ueffing, M. Two-dimensional electrophoresis of membrane proteins. Anal Bioanal Chem, 2007, 389(4), 1033-1045.
57. Castellheim, A.; Thorgersen, E.B.; Hellerud, B.C.; Pharo, A.; Johansen, H.T.; Brosstad, F.; Gaustad, P.; Brun, H.; Frosse, E.; Tonnessen, T.I.; Nielsen, E.W.; Mollnes, T.E. New Biomarkers in an Acute Model of Live Escherichia coli-induced Sepsis in Pigs. Scand J Immunol, 2008, 68, 75-84.